PortfoliosLab logoPortfoliosLab logo
HEAL.L vs. GNOG.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HEAL.L vs. GNOG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

HEAL.L is traded in USD, while GNOG.L is traded in GBP. To make them comparable, the GNOG.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, HEAL.L achieves a 0.64% return, which is significantly lower than GNOG.L's 12.00% return.


HEAL.L

1D
3.48%
1M
4.82%
YTD
0.64%
6M
-0.41%
1Y
20.32%
3Y*
6.08%
5Y*
-1.96%
10Y*

GNOG.L

1D
5.75%
1M
12.69%
YTD
12.00%
6M
10.28%
1Y
57.88%
3Y*
0.67%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEAL.L vs. GNOG.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021
HEAL.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
0.64%18.42%0.96%3.11%-24.00%-6.41%
GNOG.L
Global X Genomics & Biotechnology UCITS ETF
12.00%20.48%-18.36%-6.67%-37.25%-10.07%

Correlation

The correlation between HEAL.L and GNOG.L is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.81

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (All Time)
Calculated using the full available price history since Nov 5, 2021

0.85

The correlation between HEAL.L and GNOG.L has been stable across timeframes, ranging from 0.81 to 0.85 - a consistent structural relationship.

HEAL.L vs. GNOG.L - Sectors Allocation Comparison


Sectors
HEAL.L
GNOG.L

Healthcare

98.0%
99.7%

Technology

1.2%
0.3%

Industrials

0.5%

-

Basic Materials

0.4%

-

Financial Services

0.2%

-

Consumer Defensive

0.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

HEAL.L
98.0%
GNOG.L
99.7%

Technology

HEAL.L
1.2%
GNOG.L
0.3%

Industrials

HEAL.L
0.5%
GNOG.L

-

Basic Materials

HEAL.L
0.4%
GNOG.L

-

Financial Services

HEAL.L
0.2%
GNOG.L

-

Consumer Defensive

HEAL.L
0.1%
GNOG.L

-

Communication Services

HEAL.L

-

GNOG.L

-

Consumer Cyclical

HEAL.L

-

GNOG.L

-

Energy

HEAL.L

-

GNOG.L

-

Real Estate

HEAL.L

-

GNOG.L

-

Utilities

HEAL.L

-

GNOG.L

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HEAL.L vs. GNOG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HEAL.L
HEAL.L Risk / Return Rank: 3232
Overall Rank
HEAL.L Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
HEAL.L Sortino Ratio Rank: 3434
Sortino Ratio Rank
HEAL.L Omega Ratio Rank: 3131
Omega Ratio Rank
HEAL.L Calmar Ratio Rank: 3333
Calmar Ratio Rank
HEAL.L Martin Ratio Rank: 2828
Martin Ratio Rank

GNOG.L
GNOG.L Risk / Return Rank: 6262
Overall Rank
GNOG.L Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
GNOG.L Sortino Ratio Rank: 6565
Sortino Ratio Rank
GNOG.L Omega Ratio Rank: 5858
Omega Ratio Rank
GNOG.L Calmar Ratio Rank: 7070
Calmar Ratio Rank
GNOG.L Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEAL.L vs. GNOG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HEAL.LGNOG.LDifference
Sharpe ratioReturn per unit of total volatility

-0.88

Sortino ratioReturn per unit of downside risk

-1.06

Omega ratioGain probability vs. loss probability

1.20

1.33

-0.13

Calmar ratioReturn relative to maximum drawdown

1.61

3.05

-1.44

Martin ratioReturn relative to average drawdown

3.96

8.31

-4.35

HEAL.L vs. GNOG.L - Sharpe Ratio Comparison

The current HEAL.L Sharpe Ratio is 1.16, which is lower than the GNOG.L Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of HEAL.L and GNOG.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HEAL.LGNOG.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.16

2.04

-0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.33

-0.34

+0.67

Drawdowns

HEAL.L vs. GNOG.L - Drawdown Comparison

The maximum HEAL.L drawdown since its inception was -46.43%, smaller than the maximum GNOG.L drawdown of -69.29%. Use the drawdown chart below to compare losses from any high point for HEAL.L and GNOG.L.


Loading charts...

Drawdown Indicators


HEAL.LGNOG.LDifference

Max Drawdown

Largest peak-to-trough decline

-46.43%

-69.29%

+22.86%

Max Drawdown (1Y)

Largest decline over 1 year

-12.59%

-18.90%

+6.31%

Max Drawdown (3Y)

Largest decline over 3 years

-21.46%

-46.70%

+25.24%

Max Drawdown (5Y)

Largest decline over 5 years

-43.70%

Current Drawdown

Current decline from peak

-20.00%

-42.38%

+22.38%

Average Drawdown

Average peak-to-trough decline

-18.60%

-47.52%

+28.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.12%

6.95%

-1.83%

Volatility

HEAL.L vs. GNOG.L - Volatility Comparison

The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (HEAL.L) is 5.13%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 8.37%. This indicates that HEAL.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HEAL.LGNOG.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.13%

8.37%

-3.24%

Volatility (6M)

Calculated over the trailing 6-month period

13.28%

20.65%

-7.37%

Volatility (1Y)

Calculated over the trailing 1-year period

17.48%

28.31%

-10.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.87%

32.72%

-12.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.91%

32.72%

-12.81%

HEAL.L vs. GNOG.L - Expense Ratio Comparison

HEAL.L has a 0.40% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.


Dividends

HEAL.L vs. GNOG.L - Dividend Comparison

Neither HEAL.L nor GNOG.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


HEAL.L and GNOG.L have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, HEAL.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.

HEAL.L is cheaper with a 0.40% expense ratio, compared with 0.50% for GNOG.L.

Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: iShares and Global X. Their fees differ too: 0.40% for HEAL.L and 0.50% for GNOG.L.

Portfolio Optimizer

Find the right allocation for HEAL.L and GNOG.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer